BDBM50112656 4-[2-(2-Benzyloxycarbonylamino-4-methyl-pentanoylamino)-3-phenyl-propionylamino]-6-carbamoyl-hex-2-enoic acid ethyl ester::CHEMBL305321
SMILES: CCOC(=O)\C=C\[C@H](CCC(N)=O)NC(=O)C(Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1
InChI Key: InChIKey=VHMOHBHADBLFMA-OTSNLXBQSA-N
Data: 5 EC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Human rhinovirus A protease (Human rhinovirus B) | BDBM50112656![]() (4-[2-(2-Benzyloxycarbonylamino-4-methyl-pentanoyla...) | MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 6.30E+3 | n/a | n/a | n/a | n/a |
Pfizer Global R&D-La Jolla/Agouron Pharmaceuticals Curated by ChEMBL | Assay Description 50% effective concentration required to inhibit Human Rhinovirus 89 Protease 3C | J Med Chem 45: 2016-23 (2002) BindingDB Entry DOI: 10.7270/Q289156B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Human rhinovirus A protease (Human rhinovirus B) | BDBM50112656![]() (4-[2-(2-Benzyloxycarbonylamino-4-methyl-pentanoyla...) | MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 600 | n/a | n/a | n/a | n/a |
Pfizer Global R&D-La Jolla/Agouron Pharmaceuticals Curated by ChEMBL | Assay Description 50% effective concentration required to inhibit Human Rhinovirus 10 Protease 3C | J Med Chem 45: 2016-23 (2002) BindingDB Entry DOI: 10.7270/Q289156B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Human rhinovirus A protease (Human rhinovirus B) | BDBM50112656![]() (4-[2-(2-Benzyloxycarbonylamino-4-methyl-pentanoyla...) | MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 2.30E+3 | n/a | n/a | n/a | n/a |
Pfizer Global R&D-La Jolla/Agouron Pharmaceuticals Curated by ChEMBL | Assay Description 50% effective concentration required to inhibit Human Rhinovirus 16 Protease 3C | J Med Chem 45: 2016-23 (2002) BindingDB Entry DOI: 10.7270/Q289156B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Human rhinovirus A protease (Human rhinovirus B) | BDBM50112656![]() (4-[2-(2-Benzyloxycarbonylamino-4-methyl-pentanoyla...) | MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 540 | n/a | n/a | n/a | n/a |
Pfizer Global R&D-La Jolla/Agouron Pharmaceuticals Curated by ChEMBL | Assay Description Inhibition of Human Rhinovirus 14 (HRV14) Protease 3C | J Med Chem 45: 2016-23 (2002) BindingDB Entry DOI: 10.7270/Q289156B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Human rhinovirus A protease (Human rhinovirus B) | BDBM50112656![]() (4-[2-(2-Benzyloxycarbonylamino-4-methyl-pentanoyla...) | MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 1.60E+3 | n/a | n/a | n/a | n/a |
Pfizer Global R&D-La Jolla/Agouron Pharmaceuticals Curated by ChEMBL | Assay Description 50% effective concentration required to inhibit Human Rhinovirus 2 Protease 3C | J Med Chem 45: 2016-23 (2002) BindingDB Entry DOI: 10.7270/Q289156B | |||||||||||
More data for this Ligand-Target Pair |